Header Logo

Connection

MADHAVA BEERAM to Lymphoma, Non-Hodgkin

Back to Details
This is a "connection" page, showing publications MADHAVA BEERAM has written about Lymphoma, Non-Hodgkin.
MADHAVA BEERAM
Connection Strength
0.115
Lymphoma, Non-Hodgkin
  1. First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas. Ann Oncol. 2016 10; 27(10):1928-40.
    View in: PubMed
    Score: 0.115
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.